Melatonin synthesis in human colostrum mononuclear cells enhances dectin-1-mediated phagocytosis by mononuclear cells.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
zymosan | increase | melatonin synthesis | human colostral mononuclear cells | - | induced | #1 |
blockade of the proteasome | decrease | zymosan-induced melatonin synthesis | human colostral mononuclear cells | - | inhibits | #2 |
binding of NF-κB to DNA | decrease | zymosan-induced melatonin synthesis | human colostral mononuclear cells | - | inhibits | #3 |
melatonin | increase | zymosan-induced phagocytosis | mononuclear cells | - | increasing | #4 |
melatonin | increase | expression of dectin-1 | mononuclear cells | - | increasing | #5 |
blockade of melatonin receptors using luzindole | neutral | mononuclear cell activity | - | - | confirmed the role of melatonin | #6 |
blockade of melatonin receptors using 4P-PDOT | neutral | mononuclear cell activity | - | - | confirmed the role of melatonin | #7 |
melatonin produced by immune-competent cells | increase | clearance of pathogens | - | - | enhancing | #8 |
melatonin produced by immune-competent cells | increase | phagocyte efficiency | - | - | increasing | #9 |
Many cells in the organism besides pinealocytes, synthesize melatonin. Here, we evaluate both the mechanism of zymosan-induced melatonin synthesis and its autocrine effect in human colostral mononuclear cells. The synthesis of melatonin was induced by activation of the transcription factor nuclear factor kappa B (NF-κB), as either the blockade of the proteasome or the binding of NF-κB to DNA inhibits zymosan-induced melatonin synthesis. As observed in RAW 264.7 lineage cells, the dimer involved is RelA/c-Rel. Melatonin plays a direct role in mononuclear cell activity, increasing zymosan-induced phagocytosis by stimulating MT2 melatonin receptors and increasing the expression of dectin-1. This role was confirmed by the blockade of melatonin receptors using the competitive antagonist luzindole and the MT2 -selective partial agonist 4P-PDOT. In summary, we show that melatonin produced by immune-competent cells acts in an autocrine manner, enhancing the clearance of pathogens by increasing phagocyte efficiency. Given that these cells are present in human colostrum for 4 or 5 days after birth, this mechanism may be relevant for the protection of infant health.